Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
Tell everyone you meet this week about the organ donor register and save lives
including cancer, vaccines, a review of measures regulating the prices of medicinal products, health in the Mediterranean area, and work with health care organisations. Read more…
Now 4028 members from 106 countries
Latest news
2014-07-30
The Official Journal of the European Union (OJ)
Dods EU Alert Please click here to access Calls for proposals and related activities under the ERC Work Programme 2015 under Horizon 2020 — the Framework Programme for Research and Innovation (2014-2020). [...] Read more
2014-07-30
EASL
EASL’s flagship publication, the Journal of Hepatology has been awarded an Impact Factor of 10.401. According to Thomson Reuters, these results make the Journal of Hepatology the fastest growing and most consistently impactful hepatology publication over the past 8 years. This [...] Read more
2014-07-28
EASL
On World Hepatitis Day, organisations call on SA government: protect infants with HepB jab at birth & reduce patent barriers to HepB therapies July 28, 2014, JOHANNESBURG—On World Hepatitis Day, 22 organisations and individuals from around the world have called on the South [...] Read more
2014-07-09
Innovative Medicines Initiative (IMI)
There is nothing so far in IMI for liver disease but it is a really big piece of the Horizon 2020 research agenda so it would be good if we could put a link on this on our social media sites. Maybe one of our members will have a research idea that links liver disease with [...] Read more
2014-07-03
Italian Presidency of the Council of the European Union
The Italian Presidency of the Council of the European Union has published its 2014 health priorities including; cancer, vaccines, a review of measures regulating the prices of medicinal products and a wide ranging reflection on health in the Mediterranean area.  The intention is [...] Read more
2014-06-24
European Parliament Register
Question for written answer E-005504/2014 to the Commission Rule 117 Sergio Paolo Francesco Silvestris (PPE) Subject: Low profile of liver diseases According to some estimates, liver diseases, and cirrhosis of the liver in particular, are extremely costly in terms of human [...] Read more
2014-06-20
European Parliament Register
Source: European Parliament Register Subject: Answer to a written question on Medicines and side effects on the liver Date published: June 20 2014 Question for written answer E-005505/2014 to the Commission Rule 117 Sergio Paolo Francesco Silvestris (PPE) Subject: [...] Read more
2014-06-20
EC DG Research
EU-funded researchers are identifying and treating patients with Hepatitis B virus (HBV) in West Africa with the aim of reducing their risk of dying from liver cancer. The researchers are also developing a new test to identify those with liver cancer, so treatment can be given [...] Read more
2014-06-19
WHO
A series of policy briefs that describe practical actions to address health inequities, especially in relation to tobacco, alcohol, obesity and injury: http://www.euro.who.int/en/data-and-evidence/equity-in-health-project/policy-briefs Read more
2014-06-13
WHO, EASL
EASL took part in the first WHO global partners' meeting on hepatitis in March 2014 where participants agreed on a historic call to action to scale up the global hepatitis response. The call to action presses the global community for immediate and concerted action to increase [...] Read more